News

Mylan NV may be significantly overcharging patients for its EpiPen allergy shot. Since Mylan acquired the drug in 2007, the price has increased six-fold, from $100 to $600 for two doses. Yet Mylan pays only $34.50 per pen.

Keller Rohrback L.L.P., on behalf of the City of Tacoma, filed suit against Purdue Pharma, Endo Pharmaceuticals and Janssen Pharmaceuticals, three of the biggest manufacturers of prescription opioids in the United States.

Keller Rohrback is currently acting as co-lead counsel in Contreras v. Nationstar Mortgage L.L.C., a class action lawsuit filed against Nationstar Mortgage L.L.C.

Keller Rohrback filed a class action lawsuit against Wells Fargo Bank alleging the bank victimized its customers by charging them for auto insurance that they did not need.

Keller Rohrback is investigating reports that Wells Fargo charged auto loan borrowers millions of dollars for insurance they did not need.

As the price of EpiPen products continues to sky-rocket, a number of state legislatures have begun to take matters into their own hands.

On July 19, 2017, consumer and reseller dealer plaintiffs filed a Consolidated Class Action Complaint (link to document) in the Northern District of California.